Analysis of gene expression changes upon topobexin treatment and TOP2B-knockout in hiPSC-derived cardiomyocytes
Veronika Kerestes, Ian Cowell, Anna Jirkovska, Mushtaq Khazeem, Galina Karabanovich, Iuliia Melnikova, John Casement, Jan Kubes, Tomas Simunek, Jaroslav Roh, Matthew Schellenberg, Adam Creigh, Chunbo Yang, Majlinda Lako, Lyle Armstrong, Caroline Austin · 2026
Read Analysis of gene expression changes upon topobexin treatment and TOP2B-knockout in hiPSC-derived cardiomyocytes by Veronika Kerestes, Ian Cowell, Anna Jirkovska, Mushtaq Khazeem, Galina Karabanovich, Iuliia Melnikova, John Casement, Jan Kubes, Tomas Simunek, Jaroslav Roh, Matthew Schellenberg, Adam Creigh, Chunbo Yang, Majlinda Lako, Lyle Armstrong, Caroline Austin (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13552481.txt.
Description
The role of DNA topoisomerase II beta (TOP2B) in cardiomyocyte differentiation is poorly understood. To address this, human induced pluripotent stem cells (hiPSC) were differentiated into cardiomyocytes (CM) that were wild type (WT) or contained a genomic deletion of Topoisomerase 2B (BKO). Both WT and BKO hiPSC could be induced to differentiate into sheets of beating cardiomyocytes.
Catalog record
| CREATOR | Veronika Kerestes, Ian Cowell, Anna Jirkovska, Mushtaq Khazeem, Galina Karabanovich, Iuliia Melnikova, John Casement, Jan Kubes, Tomas Simunek, Jaroslav Roh, Matthew Schellenberg, Adam Creigh, Chunbo Yang, Majlinda Lako, Lyle Armstrong, Caroline Austin |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |